1. Home
  2. CRON vs RGR Comparison

CRON vs RGR Comparison

Compare CRON & RGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRON
  • RGR
  • Stock Information
  • Founded
  • CRON N/A
  • RGR 1949
  • Country
  • CRON Canada
  • RGR United States
  • Employees
  • CRON N/A
  • RGR N/A
  • Industry
  • CRON Medicinal Chemicals and Botanical Products
  • RGR Ordnance And Accessories
  • Sector
  • CRON Health Care
  • RGR Industrials
  • Exchange
  • CRON Nasdaq
  • RGR Nasdaq
  • Market Cap
  • CRON 684.7M
  • RGR 664.0M
  • IPO Year
  • CRON N/A
  • RGR N/A
  • Fundamental
  • Price
  • CRON $2.00
  • RGR $35.34
  • Analyst Decision
  • CRON Buy
  • RGR
  • Analyst Count
  • CRON 1
  • RGR 0
  • Target Price
  • CRON $3.50
  • RGR N/A
  • AVG Volume (30 Days)
  • CRON 1.8M
  • RGR 183.9K
  • Earning Date
  • CRON 05-08-2025
  • RGR 04-30-2025
  • Dividend Yield
  • CRON N/A
  • RGR 2.00%
  • EPS Growth
  • CRON N/A
  • RGR N/A
  • EPS
  • CRON 0.12
  • RGR 1.83
  • Revenue
  • CRON $124,589,000.00
  • RGR $534,561,000.00
  • Revenue This Year
  • CRON $25.49
  • RGR $4.74
  • Revenue Next Year
  • CRON $7.45
  • RGR N/A
  • P/E Ratio
  • CRON $16.28
  • RGR $19.14
  • Revenue Growth
  • CRON 33.92
  • RGR 0.65
  • 52 Week Low
  • CRON $1.60
  • RGR $34.11
  • 52 Week High
  • CRON $3.14
  • RGR $47.27
  • Technical
  • Relative Strength Index (RSI)
  • CRON 65.16
  • RGR 40.06
  • Support Level
  • CRON $1.81
  • RGR $32.74
  • Resistance Level
  • CRON $1.91
  • RGR $40.91
  • Average True Range (ATR)
  • CRON 0.07
  • RGR 1.27
  • MACD
  • CRON 0.02
  • RGR -0.61
  • Stochastic Oscillator
  • CRON 84.51
  • RGR 31.82

About CRON Cronos Group Inc. Common Share

Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S., the company has an option to acquire 5.9% of U.S. multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.

About RGR Sturm Ruger & Company Inc.

Sturm Ruger & Co Inc and its subsidiary are principally engaged in the design, manufacture, and sale of firearms to domestic customers. The company's design and manufacturing operations are in the United States and almost all product content is domestic. The company has two reportable operating segments: firearms and castings. The firearms segment manufactures and sells rifles, pistols, and revolvers principally to a number of federally-licensed, independent wholesale distributors located in the United States. The castings segment manufactures and sells steel investment castings and metal injection molding parts. It generates maximum income from the sale of Firearms.

Share on Social Networks: